Literature DB >> 32090409

Calcifying fibrous tumour: An IgG4-related disease or not?

Yu-Hsuan Hu1, Chen-Tang Yu2, Chih-Jung Chen1,3, Mei-Chin Wen1.   

Abstract

Calcifying fibrous tumour (CFT) has some of the histopathological features, such as abundant plasma cells and stromal fibrosis, that are exhibited by IgG4-related diseases (IgG4-RD). The possible role of IgG4-positive plasma cells in calcifying fibrous tumour was investigated. The aim of this study was to determine any potential relationship between IgG4-RD and CFT. Thirteen cases with a total of 16 CFTs were reviewed. Lesion samples were immunostained with anti-IgG4 and anti-IgG antibodies. The number of IgG4-positive and IgG-positive plasma cells (IgG + PC) and their ratios were estimated. Plasma cells were found in all tumours. IgG4-positive plasma cells ranged from 0 to 71 per high-power field (HPF; mean 17.8/HPF), and IgG + PC ranged from 2 to 93/HPF (mean 42.6/HPF). The IgG4/IgG ratio ranged from 0% to 80% (mean 29%). There were seven tumours with the ratio of IgG4/IgG + PC that exceeded 40%. Various degrees of stromal fibrosis were present in eight tumours. All tumours have variable calcification. The histopathological features of CFT were found to be similar to those of IgG4-RD. Some CFT also showed a high number of IgG4-positive plasma cells, and the ratio of IgG4/IgG + PC exceeded 40%, most notably in patients with concomitant inflammatory or autoimmune disease. The long-term follow-up showed no evidence of IgG4-RD in any of these patients. Our findings suggest that while CFT overlaps morphologically with IgG4-RD, it probably should not be classified as an IgG4-RD. ©2020 Company of the International Journal of Experimental Pathology (CIJEP).

Entities:  

Keywords:  IgG4-positive plasma cells; IgG4-related disease; calcifying fibrous tumour

Mesh:

Substances:

Year:  2020        PMID: 32090409      PMCID: PMC7306902          DOI: 10.1111/iep.12339

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  27 in total

1.  Calcifying fibrous pseudotumor affecting the retroperitoneum: could it be a new entity within the spectrum of IgG-4 sclerosing disease?

Authors:  M J Fernández Aceñero; Peter W Vorwald; Sharon Cordova Yamauchi
Journal:  Virchows Arch       Date:  2010-04-23       Impact factor: 4.064

Review 2.  IgG₄-related sclerosing disease: a novel mimic of inflammatory bowel disease.

Authors:  Neeraj Narula; Monica Vasudev; John K Marshall
Journal:  Dig Dis Sci       Date:  2010-06-03       Impact factor: 3.199

Review 3.  Autoimmune pancreatitis and IgG4-related systemic diseases.

Authors:  Lizhi Zhang; Thomas C Smyrk
Journal:  Int J Clin Exp Pathol       Date:  2010-05-25

Review 4.  Consensus statement on the pathology of IgG4-related disease.

Authors:  Vikram Deshpande; Yoh Zen; John Kc Chan; Eunhee E Yi; Yasuharu Sato; Tadashi Yoshino; Günter Klöppel; J Godfrey Heathcote; Arezou Khosroshahi; Judith A Ferry; Rob C Aalberse; Donald B Bloch; William R Brugge; Adrian C Bateman; Mollie N Carruthers; Suresh T Chari; Wah Cheuk; Lynn D Cornell; Carlos Fernandez-Del Castillo; David G Forcione; Daniel L Hamilos; Terumi Kamisawa; Satomi Kasashima; Shigeyuki Kawa; Mitsuhiro Kawano; Gregory Y Lauwers; Yasufumi Masaki; Yasuni Nakanuma; Kenji Notohara; Kazuichi Okazaki; Ji Kon Ryu; Takako Saeki; Dushyant V Sahani; Thomas C Smyrk; James R Stone; Masayuki Takahira; George J Webster; Motohisa Yamamoto; Giuseppe Zamboni; Hisanori Umehara; John H Stone
Journal:  Mod Pathol       Date:  2012-05-18       Impact factor: 7.842

5.  Clinicopathologic study of calcifying fibrous tumor of the gastrointestinal tract: a case series.

Authors:  Maryam Kherad Pezhouh; M Katayoon Rezaei; Maryam Shabihkhani; Arunima Ghosh; Deborah Belchis; Elizabeth A Montgomery; Lysandra Voltaggio
Journal:  Hum Pathol       Date:  2017-01-30       Impact factor: 3.466

Review 6.  International Consensus Guidance Statement on the Management and Treatment of IgG4-Related Disease.

Authors:  A Khosroshahi; Z S Wallace; J L Crowe; T Akamizu; A Azumi; M N Carruthers; S T Chari; E Della-Torre; L Frulloni; H Goto; P A Hart; T Kamisawa; S Kawa; M Kawano; M H Kim; Y Kodama; K Kubota; M M Lerch; M Löhr; Y Masaki; S Matsui; T Mimori; S Nakamura; T Nakazawa; H Ohara; K Okazaki; J H Ryu; T Saeki; N Schleinitz; A Shimatsu; T Shimosegawa; H Takahashi; M Takahira; A Tanaka; M Topazian; H Umehara; G J Webster; T E Witzig; M Yamamoto; W Zhang; T Chiba; J H Stone
Journal:  Arthritis Rheumatol       Date:  2015-07       Impact factor: 10.995

7.  Sclerosing angiomatoid nodular transformation of the spleen (SANT): clinicopathological study of 10 cases with or without abdominal disseminated calcifying fibrous tumors, and the presence of a significant number of IgG4+ plasma cells.

Authors:  Tseng-Tong Kuo; Tse-Ching Chen; Li-Yu Lee
Journal:  Pathol Int       Date:  2009-12       Impact factor: 2.534

8.  Calcifying fibrous tumor of the stomach: clinicopathologic and molecular study of seven cases with literature review and reappraisal of histogenesis.

Authors:  Abbas Agaimy; Michel P Bihl; Luigi Tornillo; Peter H Wünsch; Arndt Hartmann; Michal Michal
Journal:  Am J Surg Pathol       Date:  2010-02       Impact factor: 6.394

9.  Synchronous autoimmune pancreatitis and infiltrating pancreatic ductal adenocarcinoma: case report and review of the literature.

Authors:  Agnieszka K Witkiewicz; Eugene P Kennedy; Lawrence Kennyon; Charles J Yeo; Ralph H Hruban
Journal:  Hum Pathol       Date:  2008-07-11       Impact factor: 3.466

10.  Gastric calcifying fibrous tumor: A case of suspected immunoglobulin G4-related gastric disease.

Authors:  Hejun Zhang; Zhu Jin; Shigang Ding
Journal:  Saudi J Gastroenterol       Date:  2015 Nov-Dec       Impact factor: 2.485

View more
  2 in total

1.  Calcifying fibrous tumour: An IgG4-related disease or not?

Authors:  Yu-Hsuan Hu; Chen-Tang Yu; Chih-Jung Chen; Mei-Chin Wen
Journal:  Int J Exp Pathol       Date:  2020-02-23       Impact factor: 1.925

Review 2.  Calcifying fibrous tumor of the gastrointestinal tract: A clinicopathologic review and update.

Authors:  Donald Turbiville; Xuchen Zhang
Journal:  World J Gastroenterol       Date:  2020-10-07       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.